# Foundations of an Ovine Model of Fragile X Syndrome

**Authors:** Victoria Hawkins, Skye R. Rudiger, Clive J. McLaughlan, Jennifer M. Kelly, Klaus Lehnert, Jessie C. Jacobsen, Renee R. Handley, Kimiora Henare, Paul J. Verma, Russell G. Snell

PMC · DOI: 10.3390/genes17020152 · Genes · 2026-01-28

## TL;DR

Researchers created a sheep model for Fragile X Syndrome to better study the condition and test potential therapies.

## Contribution

The development of a novel ovine (sheep) model of Fragile X Syndrome using CRISPR-Cas9 gene editing.

## Key findings

- Two founder sheep with FMR1 gene knockouts were successfully generated.
- The model shows characteristics of FXS, such as increased joint flexibility in the female founder.
- The edited allele was successfully transmitted to offspring, enabling efficient breeding for treatment testing.

## Abstract

Background: Fragile X Syndrome (FXS) is an X-linked neurodevelopmental disorder characterised by intellectual disability, developmental delays, anxiety, and social and behavioural challenges. Currently, no effective treatments exist to address the root cause of FXS. Mouse models are the most widely used for studying molecular pathogenesis and conducting preclinical treatment testing. However, therapeutic interventions that show promise in rodent models have yet to succeed in clinical trials. After evaluating the current models, we have developed an ovine model to address this clinical translation gap. We expect this model to more accurately reflect the human condition in brain size, structure, and neurodevelopmental trajectory. We aim to establish this model as a valuable preclinical platform for testing therapies for FXS. Methods: To generate the sheep model, we used CRISPR-Cas9 dual-guide editing to knock out the Fragile X Messenger Ribonucleoprotein 1 (FMR1) gene in ovine embryos. Results: Two founder animals were created, one ram (male) and one ewe (female), both of which carried FMR1 gene knockouts. The ewe carries inactivating mutations on both alleles, with the edits in both animals resulting in no detectable Fragile X Messenger Ribonucleoprotein (FMRP) as expected. Both founders have undergone molecular characterisation and basic health checks, with the female founder showing increased joint flexibility, a characteristic of FXS. The ram has been used for breeding, with the successful transmission of the edited allele to his offspring. Importantly, specific lamb cohorts for postnatal treatment testing can be produced efficiently utilising accelerated breeding methods and preimplantation selection.

## Linked entities

- **Genes:** FMR1 (fragile X messenger ribonucleoprotein 1) [NCBI Gene 2332]
- **Proteins:** FMR1 (fragile X messenger ribonucleoprotein 1)
- **Diseases:** Fragile X Syndrome (MONDO:0010383)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Ggt1 (gamma-glutamyltransferase 1) [NCBI Gene 14598] {aka CD224, GGT, GGT 1, GGT-1, Ggtp, dwg}, FMR1 (fragile X messenger ribonucleoprotein 1) [NCBI Gene 2332] {aka FMRP, FRAXA, POF, POF1}, PCMTD1 [NCBI Gene 101112825], MAP2K5 (mitogen-activated protein kinase kinase 5) [NCBI Gene 5607] {aka HsT17454, MAPKK5, MEK5, PRKMK5}, Amelx (amelogenin, X-linked) [NCBI Gene 11704] {aka ALGN, AMGL, AMGX, Amel, Amg, LRAP}, MAP2K5 [NCBI Gene 101104069], alp (alopecia, recessive) [NCBI Gene 11691], Fmr1 (fragile X messenger ribonucleoprotein 1) [NCBI Gene 14265] {aka FMRP, Fmr-1}, FMR1 [NCBI Gene 101117478]
- **Diseases:** sleep abnormalities (MESH:D012893), ASD (MESH:D000067877), X-linked neurodevelopmental disorder (MESH:D038901), neurodevelopmental condition (MESH:D020763), injury to (MESH:D014947), anxiety (MESH:D001007), X-linked disorders (MESH:D040181), learning deficits (MESH:D007859), function (MESH:D003291), joint looseness (MESH:D007594), hyperactivity (MESH:D006948), dendritic spine abnormalities (MESH:D007635), FXS (MESH:D005600), seizure (MESH:D012640), neurological disorders (MESH:D009461), neonatal death (MESH:D066087), deaths (MESH:D003643), intellectual disability (MESH:D008607), social and communication anomalies (MESH:D000067404), dehydration (MESH:D003681), attention deficits (MESH:D001289), depression (MESH:D003866), developmental delay (MESH:D002658)
- **Chemicals:** Phosphate (MESH:D010710), gold (MESH:D006046), HC (MESH:D006854), water (MESH:D014867), Fenobam (MESH:C032794), DTT (MESH:D004229), SA (MESH:D000077145), FX351 (-), Chelex-100 (MESH:C024997), Calcium (MESH:D002118), creatinine (MESH:D003404), TBS-T. (MESH:C027647)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Callitrichinae sp. (species) [taxon 38020], Ovis aries (domestic sheep, species) [taxon 9940], Homo sapiens (human, species) [taxon 9606], Rodentia (rodent, order) [taxon 9989], Rattus norvegicus (brown rat, species) [taxon 10116], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986]
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940652/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940652/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940652/full.md

---
Source: https://tomesphere.com/paper/PMC12940652